Breakthrough-Therapy Designation - An FDA Perspective

N Engl J Med. 2018 Apr 12;378(15):1457-1458. doi: 10.1056/NEJMc1801222.

Publication types

  • Letter

MeSH terms

  • Drug Approval / legislation & jurisprudence*
  • Drug Discovery
  • Drugs, Investigational / therapeutic use*
  • Government Regulation
  • Humans
  • United States
  • United States Food and Drug Administration*

Substances

  • Drugs, Investigational